Erenumab Reduces Flushing and Erythema in Rosacea

A calcitonin gene-related peptide inhibitor that is FDA-approved for migraine prevention showed early promise against treatment-resistant redness and flushing of rosacea.

Related Keywords

Copenhagen ,Køavn ,Denmark ,Bispebjerg ,Hovedstaden ,Boston ,Massachusetts ,United States ,Thomas Jefferson University ,Pennsylvania ,Frederiksberg ,Nordjylland ,Northeastern University ,Flushing ,Philadelphia ,Emmy Graber ,Johns Barbieri ,Nita Kf Wienholtz ,Department Of Dermatology ,Drug Administration ,Sidney Kimmel Medical College ,University Of Copenhagen ,Frederiksberg Hospital ,Patient Self Assessment ,Flushing Assessment Tool ,Advanced Acne Therapeutics Clinic ,Dermatology Life Quality Index ,Rosacea Quality ,